Spermine is an endogenous iron chelator that inhibits ferroptosis.
Ferroptosis is an iron-dependent form of cell death driven by lipid peroxidation.
Here we identify spermine—a polyamine derived from spermidine—as an endogenous iron chelator that directly suppresses ferroptosis.
Integrating metabolomics, stable isotope tracing and biophysical studies of the interaction between spermine and Fe²⁺ ions,
we demonstrate that aldehyde dehydrogenase 18 family member A1 (ALDH18A1) promotes an alternative glutamine-dependent pathway
for de novo spermine synthesis that is distinct from the classical polyamine biosynthesis route.
ALDH18A1-mediated spermine production protects cells from ferroptotic cell death by chelating intracellular ferrous iron,
thereby limiting Fenton chemistry and subsequent lipid peroxidation. Targeting ALDH18A1 with a specific small-molecule inhibitor
or genetic ablation sensitizes cancer cells to ferroptosis in vitro and in vivo, suppresses liver tumour growth,
and mitigates tissue ischaemia–reperfusion injury. These findings reveal a metabolic vulnerability whereby cells exploit
polyamine metabolism to control iron bioavailability and ferroptosis susceptibility.
本研究首次发现精胺(spermine)作为内源性铁螯合剂直接抑制铁死亡的机制。 核心发现为:ALDH18A1通过谷氨酰胺依赖的新途径合成精胺,精胺通过螯合Fe²⁺抑制Fenton反应和脂质过氧化,从而阻断铁死亡。